Advanced search
Publication Cover
COPD: Journal of Chronic Obstructive Pulmonary Disease Volume 10, 2013 - Issue 4
Submit an article Journal homepage
1,214
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

One-Year Extension Study of ACCORD COPD I: Safety and Efficacy of Two Doses of Twice-daily Aclidinium Bromide in Patients with COPD

Anthony D’Urzoa University of Toronto,Toronto,CanadaCorrespondence[email protected]
,
Edward Kerwinb Clinical Research Institute,Medford,USA
,
Stephen Rennardc University of Nebraska Medical Center,Omaha,USA
,
Thomas Hed Forest Research Institute,Jersey City,USA
,
Esther Garcia Gile Almirall, SA,Barcelona,Spain
&
Cynthia Caractad Forest Research Institute,Jersey City,USA
, on behalf of the LAS-MD-36 study investigators
Pages 500-510 | Published online: 16 May 2013

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Arzu Ari & James B Fink. (2020) Recent advances in aerosol devices for the delivery of inhaled medications. Expert Opinion on Drug Delivery 17:2, pages 133-144.
Read now
Mario Malerba, Alessandro Radaeli, Giuseppe Santini, Jaymin Morjaria, Nadia Mores, Chiara Mondino, Giuseppe Macis & Paolo Montuschi. (2018) The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Discovery 13:6, pages 563-577.
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Maria Gabriella Matera, Alessandro Sanduzzi, Roberto Alfano & Mario Cazzola. (2016) Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema. Expert Review of Clinical Pharmacology 9:6, pages 771-777.
Read now
Marco Contoli, Paolo Solidoro, Fabiano Di Marco, Nicola Scichilone, Angelo Corsico, Fulvio Braido & Pierachille Santus. (2016) Effects of aclidinium on determinants of COPD severity: symptoms and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3043-3050.
Read now
Jose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, Maria Isabel Asensio-Cruz, Eduardo Márquez-Martín & Francisco Ortega-Ruiz. (2015) Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Preference and Adherence 9, pages 95-104.
Read now
Tony D’Urzo, James F Donohue, David Price, Marc Miravitlles & Edward Kerwin. (2015) Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:5, pages 519-532.
Read now
Igor Z Barjaktarevic, Anthony F Arredondo & Christopher B Cooper. (2015) Positioning new pharmacotherapies for COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1427-1442.
Read now
Paul W Jones. (2015) Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 677-687.
Read now
Jun Zhong & Michael Roth. (2014) Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease. Therapeutics and Clinical Risk Management 10, pages 449-453.
Read now
Debra J Reid & Alexa A Carlson. (2014) Clinical use of aclidinium in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 369-379.
Read now
Emily M. Armstrong, Bradley M. Wright, Allison Meyer, Courtney S. Watts & Kristi W. Kelley. (2014) The Role of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease. Hospital Practice 42:4, pages 99-110.
Read now

Articles from other publishers (13)

Yuji Oba, Edna Keeney, Namratta Ghatehorde & Sofia Dias. (2018) Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Yong-Bum Park, Chin Kook RheeHyoung Kyu YoonYeon-Mok OhSeong Yong LimJin Hwa LeeKwang-Ha Yoo & Joong Hyun Ahn. (2018) Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary. Tuberculosis and Respiratory Diseases 81:4, pages 261.
Crossref
Swati Gulati & J. Michael Wells. (2017) Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators. Drugs 77:6, pages 651-670.
Crossref
Hyoung Kyu YoonYong-Bum ParkChin Kook RheeJin Hwa LeeYeon-Mok Oh. (2017) Summary of the Chronic Obstructive Pulmonary Disease Clinical Practice Guideline Revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease. Tuberculosis and Respiratory Diseases 80:3, pages 230.
Crossref
Norbert Pauk. (2016) Current view of the pharmacotherapy of COPD. Interní medicína pro praxi 18:3, pages 114-119.
Crossref
Claudie Rodrigue, Marie-France Beauchesne, François Savaria, Amélie Forget, Catherine Lemière, Pierre Larivée & Lucie Blais. (2016) Adverse events among COPD patients treated with long-acting anticholinergics and β2-agonists in an outpatient respiratory clinic. Respiratory Medicine 113, pages 65-73.
Crossref
Jutta Beier. (2015) A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of chronic obstructive pulmonary disease. Clinical Investigation 5:8, pages 691-700.
Crossref
Katharina Marth, Elisabeth Schuller & Wolfgang Pohl. (2015) Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD. Respiratory Medicine 109:5, pages 616-624.
Crossref
Anthony D D’Urzo, Stephen I Rennard, Edward M Kerwin, Victor Mergel, Anne R Leselbaum & Cynthia F Caracta. (2014) Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respiratory Research 15:1.
Crossref
Han Ni, Zay Soe & Soe Moe. (2014) Aclidinium bromide for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015:4.
Crossref
Etzel Gysling. (2014) Aclidinium. pharma-kritik 36:5.
Crossref
Anthony D D'Urzo, M Reza Maleki-Yazdi & R Andrew McIvor. (2014) Evolving therapies in chronic obstructive pulmonary disease. Clinical Practice 11:3, pages 307-325.
Crossref
Alexander G. Mathioudakis, Victoria Chatzimavridou-Grigoriadou & Georgios A. Mathioudakis. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 241 256 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.